Circa successfully completes 56 M€ IPO that will be used to build its green solvent biorefinery


Type of post: NEWS IN BRIEF.

Biochemicals company Circa Group AS has successfully completed a private placement of approximately 56 M€ and the company shares has started trading on Euronext Growth Oslo. The proceeds from the private placement will be used to build its 1 kton ReSolute plant in France and to further develop its portfolio of chemical derivatives. The ReSolute plant has received a 12 M€ grant from the BBI JU.
Related posts:

Figure 1. Circa successfully completes 56 M€ IPO that will be used to build its green solvent biorefinery

This IPO initiates phase 3 of its development (the manufacture and commercialisation of levoglucosenone for industry) and is a positive signpost for the biomaterials industry as a whole. The private placement attracted strong interest from high-quality and global institutional investors and was more than 15 times oversubscribed (excluding pre-allocated shares).

Circa is a leader in the production of sustainable biochemicals. The company has a unique and patented technology called Furacell™ for making the platform biomolecule Levoglucosenone (LGO) which is the base for a range of chemicals, including the green solvent Cyrene™.

Popular Posts

UPM Lappeenranta Biorefinery

New HVO plant enters into operation in China

Levulinic acid biorefineries

Mitsui Chemicals, Neste and Toyota Tsusho join forces for industrial production of biobased plastics and chemicals

Eni, Euglena and PETRONAS to explore biorefinery opportunity in Malaysia